Cost-Effectiveness Analysis of Etanercept in the Treatment of Methotrexate-resistant Rheumatoid Arthritis
DC Field | Value |
---|---|
dc.contributor.author | 김종주 |
dc.contributor.author | 박은자 |
dc.contributor.author | 박세정 |
dc.contributor.author | 성윤경 |
dc.contributor.author | 배상철 |
dc.contributor.author | 이의경 |
dc.date.accessioned | 2017-01-25T04:13:40Z |
dc.date.available | 2017-01-25T04:13:40Z |
dc.date.issued | 2006-03-24 |
dc.identifier.issn | 0513-4242 |
dc.identifier.uri | https://repository.kihasa.re.kr/handle/201002/25322 |
dc.description.abstract | A cost effective analysis was performed for comparing leflunomide + methotrexate. etanercent monotherapy and etanercept + methtrexate for 6 months. For the patients with methotrexate-resistant RA, ACR20 data were extracted from the published clinical trials searched from Pubmed. The direct medical cost was estimated based on ACR guideline and Korean National Health Insurance reimbursement. Combination therapy of etanercept + methotrexate was found to be more cost-effective than etanercept monotherapy, which meant it was a better therapeutic strategy for methotrexate-resistant RA. |
dc.format.extent | 8 |
dc.language | kor |
dc.publisher | 대한약학회 |
dc.title | 메토트렉세이트 치료에 실패한 류마티스관절염 환자에서 에타너셉트 사용에 대한 비용-효과 분석 |
dc.title.alternative | Cost-Effectiveness Analysis of Etanercept in the Treatment of Methotrexate-resistant Rheumatoid Arthritis |
dc.type | Article |
dc.type.local | Article(Academic) |
dc.identifier.apprname | 학술논문평가 |
dc.subject.keyword | rheumatoid arthritis |
dc.subject.keyword | cost-effectiveness analysis |
dc.subject.keyword | pharmacoeconomics |
dc.subject.keyword | etanercept |
dc.contributor.affiliatedAuthor | 박은자 |
dc.identifier.url | https://scienceon.kisti.re.kr/srch/selectPORSrchArticle.do?cn=JAKO200622219593514 |
dc.citation.title | 약학회지 |
dc.citation.volume | 50 |
dc.citation.number | 2 |
dc.citation.startPage | 70 |
dc.citation.endPage | 77 |
dc.identifier.bibliographicCitation | 약학회지, vol. 50, no. 2, pp. 70 - 77 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.